Not Signed In - Chinese Patients With Chronic Hepatitis B Respond Better To Telbivudine Than Lamivudine
Mon, 27 Mar 2006 11:00 PM EST
... Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) and Novartis (NYSE: NVS) todayannounced new data that demonstrate telbivudine, an investigational oral,once-daily nucleoside analogue, provided significantly greater antiviral andclinical efficacy in Chinese patients with chronic hepatitis B (CHB) afterone-year of treatment when compared with a current standard of care,lamivudine... click link for more info. ...
Related Topics
- Lamivudine
- Hepatitis C
- Hepatitis B
- Hepatitis A
- Hepatitis
- Chinese martial arts
- Autoimmune Hepatitis
- Traditional Chinese Medicine
- Lamivudine and Zidovudine
- Hepatitis A and Hepatitis B Vaccine
- Hepatitis A Vaccine
- Hepatitis B Vaccine
- Chronic Fatigue Syndrome
- Pain - Chronic
- Chronic Pain
- Chronic Diseases
- Chronic Hepatitis B
- Chronic active hepatitis
- Chronic persistent hepatitis
- Chronic Hepatitis C: Current Disease Management
email this page
print this page
bookmark this page
feedback on this page
